{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T13:25:47Z","timestamp":1785331547251,"version":"3.55.0"},"reference-count":159,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Sichuan Science and Technology Program","award":["2025ZNSFSC1748"],"award-info":[{"award-number":["2025ZNSFSC1748"]}]},{"name":"Sichuan Science and Technology Program","award":["2024YFFK0062"],"award-info":[{"award-number":["2024YFFK0062"]}]},{"name":"Clinical Research Incubation Project of West China Hospital, Sichuan University","award":["2021HXFH018"],"award-info":[{"award-number":["2021HXFH018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12026-025-09723-5","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T05:50:44Z","timestamp":1764222644000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Macrophage-derived exosomes in autoimmune diseases: mechanistic insights and therapeutic implications"],"prefix":"10.1007","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8679-9682","authenticated-orcid":false,"given":"Anhao","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geng","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qibing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"9723_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2022.102266","volume":"80","author":"FW Miller","year":"2023","unstructured":"Miller FW. The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention. Curr Opin Immunol. 2023;80:102266. https:\/\/doi.org\/10.1016\/j.coi.2022.102266.","journal-title":"Curr Opin Immunol"},{"key":"9723_CR2","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/joim.12395","volume":"278","author":"L Wang","year":"2015","unstructured":"Wang L, Wang F, Gershwin ME. Human autoimmune diseases: a comprehensive update. J Intern Med. 2015;278:369\u201395. https:\/\/doi.org\/10.1111\/joim.12395.","journal-title":"J Intern Med"},{"key":"9723_CR3","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1172\/JCI78088","volume":"125","author":"MD Rosenblum","year":"2015","unstructured":"Rosenblum MD, Remedios KA, Abbas AK. Mechanisms of human autoimmunity. J Clin Invest. 2015;125:2228\u201333. https:\/\/doi.org\/10.1172\/JCI78088.","journal-title":"J Clin Invest"},{"key":"9723_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101174","volume":"25","author":"SY Gun","year":"2019","unstructured":"Gun SY, Lee SWL, Sieow JL, Wong SC. Targeting immune cells for cancer therapy. Redox Biol. 2019;25:101174. https:\/\/doi.org\/10.1016\/j.redox.2019.101174.","journal-title":"Redox Biol"},{"key":"9723_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40156-6","volume":"14","author":"A Garrido-Trigo","year":"2023","unstructured":"Garrido-Trigo A, Corraliza AM, Veny M, Dotti I, Mel\u00f3n-Ardanaz E, Rill A, et al. Macrophage and neutrophil heterogeneity at single-cell spatial resolution in human inflammatory bowel disease. Nat Commun. 2023;14:4506. https:\/\/doi.org\/10.1038\/s41467-023-40156-6.","journal-title":"Nat Commun"},{"key":"9723_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00514","volume":"5","author":"P Italiani","year":"2014","unstructured":"Italiani P, Boraschi D. From monocytes to M1\/M2 macrophages: phenotypical vs. functional differentiation. Front Immunol. 2014;5:514. https:\/\/doi.org\/10.3389\/fimmu.2014.00514.","journal-title":"Front Immunol"},{"key":"9723_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1465938","volume":"15","author":"Z Yang","year":"2024","unstructured":"Yang Z, Liu M, Chang Z, Du C, Yang Y, Zhang C, et al. Myeloid-derived growth factor promotes M2 macrophage polarization and attenuates Sj\u00f6gren\u2019s syndrome via suppression of the CX3CL1\/CX3CR1 axis. Front Immunol. 2024;15:1465938. https:\/\/doi.org\/10.3389\/fimmu.2024.1465938.","journal-title":"Front Immunol"},{"key":"9723_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05219-2","volume":"22","author":"J Lin","year":"2024","unstructured":"Lin J, Lin H-W, Wang Y-X, Fang Y, Jiang H-M, Li T, et al. FGF4 ameliorates the liver inflammation by reducing M1 macrophage polarization in experimental autoimmune hepatitis. J Transl Med. 2024;22:717. https:\/\/doi.org\/10.1186\/s12967-024-05219-2.","journal-title":"J Transl Med"},{"key":"9723_CR9","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nri3073","volume":"11","author":"PJ Murray","year":"2011","unstructured":"Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol. 2011;11:723\u201337. https:\/\/doi.org\/10.1038\/nri3073.","journal-title":"Nat Rev Immunol"},{"key":"9723_CR10","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.it.2004.09.015","volume":"25","author":"A Mantovani","year":"2004","unstructured":"Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004;25:677\u201386. https:\/\/doi.org\/10.1016\/j.it.2004.09.015.","journal-title":"Trends Immunol"},{"key":"9723_CR11","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau8587","volume":"11","author":"D Kuo","year":"2019","unstructured":"Kuo D, Ding J, Cohn IS, Zhang F, Wei K, Rao DA, et al. HBEGF\u2009+\u2009macrophages in rheumatoid arthritis induce fibroblast invasiveness. Sci Transl Med. 2019;11:eaau8587. https:\/\/doi.org\/10.1126\/scitranslmed.aau8587.","journal-title":"Sci Transl Med"},{"key":"9723_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25246-7","volume":"12","author":"X Wu","year":"2021","unstructured":"Wu X, Liu Y, Jin S, Wang M, Jiao Y, Yang B. Single-cell sequencing of immune cells from anticitrullinated peptide antibody positive and negative rheumatoid arthritis. Nat Commun. 2021;12:4977. https:\/\/doi.org\/10.1038\/s41467-021-25246-7.","journal-title":"Nat Commun"},{"key":"9723_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1076700","volume":"13","author":"D Fritz","year":"2022","unstructured":"Fritz D, Inamo J, Zhang F. Single-cell computational machine learning approaches to immune-mediated inflammatory disease: new tools uncover novel fibroblast and macrophage interactions driving pathogenesis. Front Immunol. 2022;13:1076700. https:\/\/doi.org\/10.3389\/fimmu.2022.1076700.","journal-title":"Front Immunol"},{"key":"9723_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.593300","volume":"11","author":"P Saas","year":"2020","unstructured":"Saas P, Chagu\u00e9 C, Maraux M, Cherrier T. Toward the characterization of human pro-resolving macrophages? Front Immunol. 2020;11:593300. https:\/\/doi.org\/10.3389\/fimmu.2020.593300.","journal-title":"Front Immunol"},{"key":"9723_CR15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s11596-024-2861-7","volume":"44","author":"Y Xu","year":"2024","unstructured":"Xu Y, Jiang T, Yang X, Chen Z. Methods, mechanisms, and application prospects for enhancing extracellular vesicle uptake. Curr Med Sci. 2024;44:247\u201360. https:\/\/doi.org\/10.1007\/s11596-024-2861-7.","journal-title":"Curr Med Sci"},{"key":"9723_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01912","volume":"11","author":"H Liu","year":"2020","unstructured":"Liu H, Li R, Liu T, Yang L, Yin G, Xie Q. Immunomodulatory effects of mesenchymal stem cells and mesenchymal stem cell-derived extracellular vesicles in rheumatoid arthritis. Front Immunol. 2020;11:1912. https:\/\/doi.org\/10.3389\/fimmu.2020.01912.","journal-title":"Front Immunol"},{"key":"9723_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202101090","volume":"8","author":"J Li","year":"2021","unstructured":"Li J, Zheng M, Shimoni O, Banks WA, Bush AI, Gamble JR, et al. Development of novel therapeutics targeting the blood-brain barrier: from barrier to carrier. Adv Sci. 2021;8:e2101090. https:\/\/doi.org\/10.1002\/advs.202101090.","journal-title":"Adv Sci"},{"key":"9723_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242115635","volume":"24","author":"Z Osaid","year":"2023","unstructured":"Osaid Z, Haider M, Hamoudi R, Harati R. Exosomes interactions with the blood-brain barrier: implications for cerebral disorders and therapeutics. Int J Mol Sci. 2023;24:15635. https:\/\/doi.org\/10.3390\/ijms242115635.","journal-title":"Int J Mol Sci"},{"key":"9723_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.114820","volume":"197","author":"JR Wu","year":"2023","unstructured":"Wu JR, Hernandez Y, Miyasaki KF, Kwon EJ. Engineered nanomaterials that exploit blood-brain barrier dysfunction for delivery to the brain. Adv Drug Deliv Rev. 2023;197:114820. https:\/\/doi.org\/10.1016\/j.addr.2023.114820.","journal-title":"Adv Drug Deliv Rev"},{"key":"9723_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-63348-8","volume":"16","author":"X Yu","year":"2025","unstructured":"Yu X, Zhang M, Kang N, Li C, Wang Z, Ao Y, et al. Defective neutrophil-derived exosomes facilitate macrophage activation through miR-122-5p in beh\u00e7et\u2019s disease. Nat Commun. 2025;16:8186. https:\/\/doi.org\/10.1038\/s41467-025-63348-8.","journal-title":"Nat Commun"},{"key":"9723_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.785728","volume":"12","author":"Y Xing","year":"2021","unstructured":"Xing Y, Sun X, Dou Y, Wang M, Zhao Y, Yang Q. The immuno-modulation effect of macrophage-derived extracellular vesicles in chronic inflammatory diseases. Front Immunol. 2021;12:785728. https:\/\/doi.org\/10.3389\/fimmu.2021.785728.","journal-title":"Front Immunol"},{"key":"9723_CR22","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s00262-020-02762-x","volume":"70","author":"M Moradi-Chaleshtori","year":"2021","unstructured":"Moradi-Chaleshtori M, Bandehpour M, Soudi S, Mohammadi-Yeganeh S, Hashemi SM. In vitro and in vivo evaluation of anti-tumoral effect of M1 phenotype induction in macrophages by miR-130 and miR-33 containing exosomes. Cancer Immunol Immunother. 2021;70:1323\u201339. https:\/\/doi.org\/10.1007\/s00262-020-02762-x.","journal-title":"Cancer Immunol Immunother"},{"key":"9723_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201900513","volume":"6","author":"H Kim","year":"2019","unstructured":"Kim H, Wang SY, Kwak G, Yang Y, Kwon IC, Kim SH. Exosome-guided phenotypic switch of M1 to M2 macrophages for cutaneous wound healing. Adv Sci. 2019;6:1900513. https:\/\/doi.org\/10.1002\/advs.201900513.","journal-title":"Adv Sci"},{"key":"9723_CR24","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1021\/acsbiomaterials.3c01833","volume":"10","author":"Q Yuan","year":"2024","unstructured":"Yuan Q, Yang M, Zheng H, Cai Y, Luo P, Wang X, et al. M2 macrophage-derived extracellular vesicles encapsulated in hyaluronic acid alleviate osteoarthritis by modulating macrophage polarization. ACS Biomater Sci Eng. 2024;10:3355\u201377. https:\/\/doi.org\/10.1021\/acsbiomaterials.3c01833.","journal-title":"ACS Biomater Sci Eng"},{"key":"9723_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106551","volume":"84","author":"M Zhu","year":"2020","unstructured":"Zhu M, Sun X, Qi X, Xia L, Wu Y. Exosomes from high glucose-treated macrophages activate macrophages andinduce inflammatory responses via NF-\u03baB signaling pathway in vitro and in vivo. Int Immunopharmacol. 2020;84:106551. https:\/\/doi.org\/10.1016\/j.intimp.2020.106551.","journal-title":"Int Immunopharmacol"},{"key":"9723_CR26","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1146\/annurev.immunol.19.1.93","volume":"19","author":"JL Flynn","year":"2001","unstructured":"Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol. 2001;19:93\u2013129. https:\/\/doi.org\/10.1146\/annurev.immunol.19.1.93.","journal-title":"Annu Rev Immunol"},{"key":"9723_CR27","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.tube.2004.10.001","volume":"85","author":"ER Rhoades","year":"2005","unstructured":"Rhoades ER, Geisel RE, Butcher BA, McDonough S, Russell DG. Cell wall lipids from Mycobacterium bovis BCG are inflammatory when inoculated within a gel matrix: characterization of a new model of the granulomatous response to mycobacterial components. Tuberculosis. 2005;85:159\u201376. https:\/\/doi.org\/10.1016\/j.tube.2004.10.001.","journal-title":"Tuberculosis"},{"key":"9723_CR28","doi-asserted-by":"publisher","first-page":"5007","DOI":"10.4049\/jimmunol.174.8.5007","volume":"174","author":"RE Geisel","year":"2005","unstructured":"Geisel RE, Sakamoto K, Russell DG, Rhoades ER. In vivo activity of released cell wall lipids of mycobacterium bovis bacillus calmette-gu\u00e9rin is due principally to trehalose mycolates. J Immunol. 2005;174:5007\u201315. https:\/\/doi.org\/10.4049\/jimmunol.174.8.5007.","journal-title":"J Immunol"},{"key":"9723_CR29","doi-asserted-by":"publisher","first-page":"777","DOI":"10.4049\/jimmunol.1103638","volume":"189","author":"PP Singh","year":"2012","unstructured":"Singh PP, Smith VL, Karakousis PC, Schorey JS. Exosomes isolated from mycobacteria-infected mice or cultured macrophages can recruit and activate immune cells in vitro and in vivo. J Immunol. 2012;189:777\u201385. https:\/\/doi.org\/10.4049\/jimmunol.1103638.","journal-title":"J Immunol"},{"key":"9723_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00074","volume":"11","author":"M Quaglia","year":"2020","unstructured":"Quaglia M, Dellepiane S, Guglielmetti G, Merlotti G, Castellano G, Cantaluppi V. Extracellular vesicles as mediators of cellular crosstalk between immune system and kidney graft. Front Immunol. 2020;11:74. https:\/\/doi.org\/10.3389\/fimmu.2020.00074.","journal-title":"Front Immunol"},{"key":"9723_CR31","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1016\/j.molimm.2007.11.021","volume":"45","author":"K Papp","year":"2008","unstructured":"Papp K, V\u00e9gh P, Prechl J, Kerekes K, Kov\u00e1cs J, Csik\u00f3s G, et al. B lymphocytes and macrophages release cell membrane deposited C3-fragments on exosomes with T cell response-enhancing capacity\u2606. Mol Immunol. 2008;45:2343\u201351. https:\/\/doi.org\/10.1016\/j.molimm.2007.11.021.","journal-title":"Mol Immunol"},{"key":"9723_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.572689","volume":"8","author":"Z Li","year":"2020","unstructured":"Li Z, Suo B, Long G, Gao Y, Song J, Zhang M, et al. Exosomal miRNA-16-5p derived from M1 macrophages enhances T cell-dependent immune response by regulating PD-L1 in gastric cancer. Front Cell Dev Biol. 2020;8:572689. https:\/\/doi.org\/10.3389\/fcell.2020.572689.","journal-title":"Front Cell Dev Biol"},{"key":"9723_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002461","volume":"3","author":"PK Giri","year":"2008","unstructured":"Giri PK, Schorey JS. Exosomes derived from M. bovis BCG infected macrophages activate antigen-specific CD4\u2009+\u2009and CD8\u2009+\u2009T cells in vitro and in vivo. PLoS One. 2008;3:e2461. https:\/\/doi.org\/10.1371\/journal.pone.0002461.","journal-title":"PLoS One"},{"key":"9723_CR34","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1093\/ecco-jcc\/jjaa083","volume":"14","author":"H Liu","year":"2020","unstructured":"Liu H, Liang Z, Wang F, Zheng X, Zeng Z, He X, et al. Intestinal CD14\u2009+\u2009macrophages protect CD4\u2009+\u2009T cells from activation-induced cell death via exosomal membrane TNF in Crohn\u2019s disease. J Crohns Colitis. 2020;14:1619\u201331. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaa083.","journal-title":"J Crohns Colitis"},{"key":"9723_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02346","volume":"10","author":"R Yang","year":"2019","unstructured":"Yang R, Liao Y, Wang L, He P, Hu Y, Yuan D, et al. Exosomes derived from M2b macrophages attenuate DSS-induced colitis. Front Immunol. 2019;10:2346. https:\/\/doi.org\/10.3389\/fimmu.2019.02346.","journal-title":"Front Immunol"},{"key":"9723_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-020-1163-9","volume":"20","author":"F Yang","year":"2020","unstructured":"Yang F, Wang T, Du P, Fan H, Dong X, Guo H. M2 bone marrow-derived macrophage-derived exosomes shuffle microRNA-21 to accelerate immune escape of glioma by modulating PEG3. Cancer Cell Int. 2020;20:93. https:\/\/doi.org\/10.1186\/s12935-020-1163-9.","journal-title":"Cancer Cell Int"},{"key":"9723_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155255","volume":"124","author":"W-W Cai","year":"2024","unstructured":"Cai W-W, Gao Y, Cheng J-W, Yu Y, Zong S-Y, Li Y-H, et al. Berberine modulates the immunometabolism and differentiation of CD4\u2009+\u2009T cells alleviating experimental arthritis by suppression of M1-exo-miR155. Phytomedicine. 2024;124:155255. https:\/\/doi.org\/10.1016\/j.phymed.2023.155255.","journal-title":"Phytomedicine"},{"key":"9723_CR38","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200851","volume":"218","author":"WH Fridman","year":"2021","unstructured":"Fridman WH, Petitprez F, Meylan M, Chen TW-W, Sun C-M, Roumenina LT, et al. B cells and cancer: to B or not to B? J Exp Med. 2021;218:e20200851. https:\/\/doi.org\/10.1084\/jem.20200851.","journal-title":"J Exp Med"},{"key":"9723_CR39","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/nm.3680","volume":"20","author":"EC Rosser","year":"2014","unstructured":"Rosser EC, Oleinika K, Tonon S, Doyle R, Bosma A, Carter NA, et al. Regulatory B cells are induced by gut microbiota\u2013driven interleukin-1\u03b2 and interleukin-6 production. Nat Med. 2014;20:1334\u20139. https:\/\/doi.org\/10.1038\/nm.3680.","journal-title":"Nat Med"},{"key":"9723_CR40","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/imr.12610","volume":"281","author":"EY Bassoy","year":"2018","unstructured":"Bassoy EY, Towne JE, Gabay C. Regulation and function of interleukin-36 cytokines. Immunol Rev. 2018;281:169\u201378. https:\/\/doi.org\/10.1111\/imr.12610.","journal-title":"Immunol Rev"},{"key":"9723_CR41","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/cei.12761","volume":"184","author":"M-A Boutet","year":"2016","unstructured":"Boutet M-A, Bart G, Penhoat M, Amiaud J, Brulin B, Charrier C, et al. Distinct expression of interleukin (IL)-36\u03b1, \u03b2 and \u03b3, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and crohn\u2019s disease. Clin Exp Immunol. 2016;184:159\u201373. https:\/\/doi.org\/10.1111\/cei.12761.","journal-title":"Clin Exp Immunol"},{"key":"9723_CR42","doi-asserted-by":"publisher","first-page":"5813","DOI":"10.1182\/blood-2011-05-356873","volume":"118","author":"S Vigne","year":"2011","unstructured":"Vigne S, Palmer G, Lamacchia C, Martin P, Talabot-Ayer D, Rodriguez E, et al. IL-36R ligands are potent regulators of dendritic and T cells. Blood. 2011;118:5813\u201323. https:\/\/doi.org\/10.1182\/blood-2011-05-356873.","journal-title":"Blood"},{"key":"9723_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2022.100519","volume":"23","author":"IC Scott","year":"2022","unstructured":"Scott IC, Whittle R, Bailey J, Twohig H, Hider SL, Mallen CD, et al. Rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis epidemiology in England from 2004 to 2020: an observational study using primary care electronic health record data. Lancet Reg Health. 2022;23:100519. https:\/\/doi.org\/10.1016\/j.lanepe.2022.100519.","journal-title":"Lancet Reg Health"},{"key":"9723_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01952-8","volume":"9","author":"Y Song","year":"2024","unstructured":"Song Y, Li J, Wu Y. Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders. Signal Transduct Target Ther. 2024;9:263. https:\/\/doi.org\/10.1038\/s41392-024-01952-8.","journal-title":"Signal Transduct Target Ther"},{"key":"9723_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.724934","volume":"12","author":"R Yu","year":"2021","unstructured":"Yu R, Zhang J, Zhuo Y, Hong X, Ye J, Tang S, et al. Identification of diagnostic signatures and immune cell infiltration characteristics in rheumatoid arthritis by integrating bioinformatic analysis and machine-learning strategies. Front Immunol. 2021;12:724934. https:\/\/doi.org\/10.3389\/fimmu.2021.724934.","journal-title":"Front Immunol"},{"key":"9723_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121578","volume":"286","author":"H Kim","year":"2022","unstructured":"Kim H, Back JH, Han G, Lee SJ, Park YE, Gu MB, et al. Extracellular vesicle-guided in situ reprogramming of synovial macrophages for the treatment of rheumatoid arthritis. Biomaterials. 2022;286:121578. https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121578.","journal-title":"Biomaterials"},{"key":"9723_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2024.106936","volume":"270","author":"F Fang","year":"2024","unstructured":"Fang F, Hua M, Yu G. Study of the mechanism of fibroblast-like synoviocytes-derived exosomes inducing macrophages M1 polarization and CD8\u2009+\u2009T cells immune regulation ferroptosis and autophagy in rheumatoid arthritis. Immunol Lett. 2024;270:106936. https:\/\/doi.org\/10.1016\/j.imlet.2024.106936.","journal-title":"Immunol Lett"},{"key":"9723_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02444-1","volume":"22","author":"H Liu","year":"2024","unstructured":"Liu H, Chen Y, Huang Y, Wei L, Ran J, Li Q, et al. Macrophage-derived miR-100-5p orchestrates synovial proliferation and inflammation in rheumatoid arthritis through mTOR signaling. J Nanobiotechnol. 2024;22:197. https:\/\/doi.org\/10.1186\/s12951-024-02444-1.","journal-title":"J Nanobiotechnol"},{"key":"9723_CR49","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adj1252","volume":"10","author":"MM Hanlon","year":"2024","unstructured":"Hanlon MM, Smith CM, Canavan M, Neto NGB, Song Q, Lewis MJ, et al. Loss of synovial tissue macrophage homeostasis precedes rheumatoid arthritis clinical onset. Sci Adv. 2024;10:eadj1252. https:\/\/doi.org\/10.1126\/sciadv.adj1252.","journal-title":"Sci Adv"},{"key":"9723_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e35589","volume":"10","author":"Y Guan","year":"2024","unstructured":"Guan Y, Li X, Yang H, Xu S, Shi L, Liu Y, et al. Role and mechanism of IRF9 in promoting the progression of rheumatoid arthritis by regulating macrophage polarization via PSMA5. Heliyon. 2024;10:e35589. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e35589.","journal-title":"Heliyon"},{"key":"9723_CR51","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/s41584-022-00790-8","volume":"18","author":"M Kurowska-Stolarska","year":"2022","unstructured":"Kurowska-Stolarska M, Alivernini S. Synovial tissue macrophages in joint homeostasis, rheumatoid arthritis and disease remission. Nat Rev Rheumatol. 2022;18:384\u201397. https:\/\/doi.org\/10.1038\/s41584-022-00790-8.","journal-title":"Nat Rev Rheumatol"},{"key":"9723_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156232","volume":"135","author":"Y Ling","year":"2024","unstructured":"Ling Y, Yang Y, Ren N, Xu H, Cheng C, Lu D, et al. Jinwu jiangu capsule attenuates rheumatoid arthritis via the SLC7A11\/GSH\/GPX4 pathway in M1 macrophages. Phytomedicine. 2024;135:156232. https:\/\/doi.org\/10.1016\/j.phymed.2024.156232.","journal-title":"Phytomedicine"},{"key":"9723_CR53","doi-asserted-by":"publisher","first-page":"119307","DOI":"10.1016\/j.jep.2024.119307","volume":"341","author":"P Liu","year":"2024","unstructured":"Liu P, Chen Z, Huang J, Wang X, Chen Y, He X, et al. Wutou decoction: a latest review on molecular mechanisms, clinical studies, quality control, Pharmacokinetic studies, Pharmacological effects, toxicity, and target prediction. J Ethnopharmacol. 2024;341:119307. https:\/\/doi.org\/10.1016\/j.jep.2024.119307.","journal-title":"J Ethnopharmacol"},{"key":"9723_CR54","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-024-02145-9","author":"W Fu","year":"2024","unstructured":"Fu W, Fang Y, Wang T, Lu Q, Wu J, Yang Q. Low-protein diet inhibits the synovial tissue macrophage pro-inflammatory polarization via NRF2\/SIRT3\/SOD2\/ROS pathway in K\/BxN rheumatoid arthritis mice. Inflammation. 2024. https:\/\/doi.org\/10.1007\/s10753-024-02145-9.","journal-title":"Inflammation"},{"key":"9723_CR55","doi-asserted-by":"publisher","first-page":"113855","DOI":"10.1016\/j.intimp.2024.113855","volume":"146","author":"Y Zhendong","year":"2024","unstructured":"Zhendong Y, Changjun C, Haocheng H, Qibin L, Dailing C, Linsong T, et al. Regulation of macrophage polarization and pyroptosis by 4-methylcatechol alleviates collagen-induced arthritis via Nrf2\/HO-1 and NF-\u03baB\/NLRP3 signaling pathways. Int Immunopharmacol. 2024;146:113855. https:\/\/doi.org\/10.1016\/j.intimp.2024.113855.","journal-title":"Int Immunopharmacol"},{"key":"9723_CR56","doi-asserted-by":"publisher","first-page":"17802","DOI":"10.1021\/acsnano.2c08774","volume":"16","author":"R Tenchov","year":"2022","unstructured":"Tenchov R, Sasso JM, Wang X, Liaw W-S, Chen C-A, Zhou QA. Exosomesnature\u2019s lipid nanoparticles, a rising star in drug delivery and diagnostics. ACS Nano. 2022;16:17802\u201346. https:\/\/doi.org\/10.1021\/acsnano.2c08774.","journal-title":"ACS Nano"},{"key":"9723_CR57","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jconrel.2021.11.019","volume":"341","author":"H Li","year":"2022","unstructured":"Li H, Feng Y, Zheng X, Jia M, Mei Z, Wang Y, et al. M2-type exosomes nanoparticles for rheumatoid arthritis therapy via macrophage re-polarization. J Control Release. 2022;341:16\u201330. https:\/\/doi.org\/10.1016\/j.jconrel.2021.11.019.","journal-title":"J Control Release"},{"key":"9723_CR58","doi-asserted-by":"publisher","first-page":"7862","DOI":"10.1039\/d2tb01219g","volume":"10","author":"Y Tang","year":"2022","unstructured":"Tang Y, Wu Z, Guo R, Huang J, Rong X, Zhu B, et al. Ultrasound-augmented anti-inflammatory exosomes for targeted therapy in rheumatoid arthritis. J Mater Chem B. 2022;10:7862\u201374. https:\/\/doi.org\/10.1039\/d2tb01219g.","journal-title":"J Mater Chem B"},{"key":"9723_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111604","volume":"129","author":"J Gong","year":"2024","unstructured":"Gong J, Zhang X, Khan A, Liang J, Xiong T, Yang P, et al. Identification of serum exosomal miRNA biomarkers for diagnosis of rheumatoid arthritis. Int Immunopharmacol. 2024;129:111604. https:\/\/doi.org\/10.1016\/j.intimp.2024.111604.","journal-title":"Int Immunopharmacol"},{"key":"9723_CR60","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1016\/S0140-6736(19)30237-5","volume":"393","author":"L Durcan","year":"2019","unstructured":"Durcan L, O\u2019Dwyer T, Petri M. Management strategies and future directions for systemic lupus erythematosus in adults. Lancet. 2019;393:2332\u201343. https:\/\/doi.org\/10.1016\/S0140-6736(19)30237-5.","journal-title":"Lancet"},{"key":"9723_CR61","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1016\/S0140-6736(19)30546-X","volume":"393","author":"T D\u00f6rner","year":"2019","unstructured":"D\u00f6rner T, Furie R. Novel paradigms in systemic lupus erythematosus. Lancet. 2019;393:2344\u201358. https:\/\/doi.org\/10.1016\/S0140-6736(19)30546-X.","journal-title":"Lancet"},{"key":"9723_CR62","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/35075603","volume":"411","author":"RS Scott","year":"2001","unstructured":"Scott RS, McMahon EJ, Pop SM, Reap EA, Caricchio R, Cohen PL, et al. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature. 2001;411:207\u201311. https:\/\/doi.org\/10.1038\/35075603.","journal-title":"Nature"},{"key":"9723_CR63","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1084\/jem.192.3.359","volume":"192","author":"PR Taylor","year":"2000","unstructured":"Taylor PR, Carugati A, Fadok VA, Cook HT, Andrews M, Carroll MC, et al. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J Exp Med. 2000;192:359\u201366. https:\/\/doi.org\/10.1084\/jem.192.3.359.","journal-title":"J Exp Med"},{"key":"9723_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02058","volume":"10","author":"C Burbano","year":"2019","unstructured":"Burbano C, Villar-Vesga J, V\u00e1squez G, Mu\u00f1oz-Vahos C, Rojas M, Casta\u00f1o D. Proinflammatory differentiation of macrophages through microparticles that form immune complexes leads to T- and B-cell activation in systemic autoimmune diseases. Front Immunol. 2019;10:2058. https:\/\/doi.org\/10.3389\/fimmu.2019.02058.","journal-title":"Front Immunol"},{"key":"9723_CR65","doi-asserted-by":"publisher","first-page":"1329009","DOI":"10.3389\/fimmu.2024.1329009","volume":"15","author":"Z Sun","year":"2024","unstructured":"Sun Z, Gao Z, Xiang M, Feng Y, Wang J, Xu J, et al. Comprehensive analysis of lactate-related gene profiles and immune characteristics in lupus nephritis. Front Immunol. 2024;15:1329009. https:\/\/doi.org\/10.3389\/fimmu.2024.1329009.","journal-title":"Front Immunol"},{"key":"9723_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2024.148289","volume":"908","author":"F Chai","year":"2024","unstructured":"Chai F, Chang X, Lin Y, Pang X, Luo S, Huang H, et al. Effect of M0 macrophage-derived exosome miR-181d-5p targeting BCL-2 to regulate NLRP3\/caspase-1\/GSDMD pathway on human renal mesangial cells pyroptosis. Gene. 2024;908:148289. https:\/\/doi.org\/10.1016\/j.gene.2024.148289.","journal-title":"Gene"},{"key":"9723_CR67","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/path.6331","volume":"264","author":"T Zoshima","year":"2024","unstructured":"Zoshima T, Baba T, Nakatani K, Nagata M, Mukaida N, Kawano M. The CCL2-CCR2 axis determines whether glomerular endocapillary hypercellularity or wire-loop lesions develop through glomerular macrophage and neutrophil infiltration in lupus nephritis. J Pathol. 2024;264:174\u201385. https:\/\/doi.org\/10.1002\/path.6331.","journal-title":"J Pathol"},{"key":"9723_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-024-03311-y","volume":"26","author":"S Wei","year":"2024","unstructured":"Wei S, Shen H, Zhang Y, Liu C, Li S, Yao J, et al. Integrative analysis of single-cell and bulk transcriptome data reveal the significant role of macrophages in lupus nephritis. Arthritis Res Ther. 2024;26:84. https:\/\/doi.org\/10.1186\/s13075-024-03311-y.","journal-title":"Arthritis Res Ther"},{"key":"9723_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2024.110285","volume":"265","author":"J-H Lai","year":"2024","unstructured":"Lai J-H, Wu D-W, Huang C-Y, Hung L-F, Wu C-H, Ho L-J. USP18 induction regulates immunometabolism to attenuate M1 signal-polarized macrophages and enhance IL-4-polarized macrophages in systemic lupus erythematosus. Clin Immunol (Orlando Fla). 2024;265:110285. https:\/\/doi.org\/10.1016\/j.clim.2024.110285.","journal-title":"Clin Immunol (Orlando Fla)"},{"key":"9723_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-024-00866-z","volume":"30","author":"L Zhao","year":"2024","unstructured":"Zhao L, Tang S, Chen F, Ren X, Han X, Zhou X. Regulation of macrophage polarization by targeted metabolic reprogramming for the treatment of lupus nephritis. Mol Med. 2024;30:96. https:\/\/doi.org\/10.1186\/s10020-024-00866-z.","journal-title":"Mol Med"},{"key":"9723_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-021-00650-x","volume":"19","author":"SM Al-Mayouf","year":"2021","unstructured":"Al-Mayouf SM, Al Mutairi M, Bouayed K, Habjoka S, Hadef D, Lotfy HM, et al. Epidemiology and demographics of juvenile idiopathic arthritis in Africa and Middle East. Pediatr Rheumatol Online J. 2021;19:166. https:\/\/doi.org\/10.1186\/s12969-021-00650-x.","journal-title":"Pediatr Rheumatol Online J"},{"key":"9723_CR72","doi-asserted-by":"publisher","first-page":"e5131","DOI":"10.7759\/cureus.5131","volume":"11","author":"A Patwardhan","year":"2019","unstructured":"Patwardhan A. The utility and experience with disease biomarkers in juvenile onset arthritis vs. adult onset arthritis. Cureus. 2019;11:e5131. https:\/\/doi.org\/10.7759\/cureus.5131.","journal-title":"Cureus"},{"key":"9723_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-021-00629-8","volume":"19","author":"LN Zaripova","year":"2021","unstructured":"Zaripova LN, Midgley A, Christmas SE, Beresford MW, Baildam EM, Oldershaw RA. Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches. Pediatr Rheumatol Online J. 2021;19:135. https:\/\/doi.org\/10.1186\/s12969-021-00629-8.","journal-title":"Pediatr Rheumatol Online J"},{"key":"9723_CR74","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/annrheumdis-2015-208982","volume":"75","author":"A Ravelli","year":"2016","unstructured":"Ravelli A, Minoia F, Dav\u00ec S, Horne A, Bovis F, Pistorio A, et al. 2016 classification criteria for Macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Ann Rheum Dis. 2016;75:481\u20139. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208982.","journal-title":"Ann Rheum Dis"},{"key":"9723_CR75","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/art.42666","volume":"76","author":"K Khanna","year":"2024","unstructured":"Khanna K, Yan H, Mehra M, Rohatgi N, Mbalaviele G, Mellins ED, et al. Tmem178 negatively regulates IL-1\u03b2 production through inhibition of the NLRP3 inflammasome. Arthritis Rheumatol. 2024;76:107\u201318. https:\/\/doi.org\/10.1002\/art.42666.","journal-title":"Arthritis Rheumatol"},{"key":"9723_CR76","doi-asserted-by":"publisher","first-page":"SI167","DOI":"10.1093\/rheumatology\/keae124","volume":"63","author":"K Ulu","year":"2024","unstructured":"Ulu K, Aliyev E, K\u0131l\u0131\u00e7 K\u00f6nte E, Tanatar A, T\u00fcrkmen \u015e, Do\u011fantan \u015e, et al. Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis on anti-interleukin-1 or -6 therapy. Rheumatol (Oxf Engl). 2024;63:SI167\u201372. https:\/\/doi.org\/10.1093\/rheumatology\/keae124.","journal-title":"Rheumatol (Oxf Engl)"},{"key":"9723_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1228122","volume":"14","author":"A Cambon","year":"2023","unstructured":"Cambon A, Rebelle C, Bachelier R, Arnaud L, Robert S, Lagarde M, et al. Macrophage IL-1\u03b2-positive microvesicles exhibit thrombo-inflammatory properties and are detectable in patients with active juvenile idiopathic arthritis. Front Immunol. 2023;14:1228122. https:\/\/doi.org\/10.3389\/fimmu.2023.1228122.","journal-title":"Front Immunol"},{"key":"9723_CR78","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.4049\/jimmunol.179.3.1913","volume":"179","author":"Y Qu","year":"2007","unstructured":"Qu Y, Franchi L, Nunez G, Dubyak GR. Nonclassical IL-1 beta secretion stimulated by P2X7 receptors is dependent on inflammasome activation and correlated with exosome release in murine macrophages. J Immunol (baltim Md : 1950). 2007;179:1913\u201325. https:\/\/doi.org\/10.4049\/jimmunol.179.3.1913.","journal-title":"J Immunol (baltim Md : 1950)"},{"key":"9723_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-024-00974-4","volume":"22","author":"L Qiu","year":"2024","unstructured":"Qiu L, Ma L, Xie Y, Jin J, Pan Y, Li S, et al. Efficacy and safety of Canakinumab in systemic juvenile idiopathic arthritis, the first Chinese experience. Pediatr Rheumatol Online J. 2024;22:38. https:\/\/doi.org\/10.1186\/s12969-024-00974-4.","journal-title":"Pediatr Rheumatol Online J"},{"key":"9723_CR80","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1007\/s10067-024-07126-9","volume":"43","author":"C Li","year":"2024","unstructured":"Li C, Tang X, Zhou Z, Sun L, Lu M, Zhou W, et al. Efficacy and safety of tocilizumab in Chinese patients with systemic juvenile idiopathic arthritis: a multicentre phase IV trial. Clin Rheumatol. 2024;43:3457\u201367. https:\/\/doi.org\/10.1007\/s10067-024-07126-9.","journal-title":"Clin Rheumatol"},{"key":"9723_CR81","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1007\/s00296-024-05658-6","volume":"44","author":"J Ant\u00f3n","year":"2024","unstructured":"Ant\u00f3n J, Mosquera JM, Calzada J, Iglesias E, Zacar\u00edas A, Oliv\u00e9 A, et al. Similarities and differences between systemic juvenile idiopathic arthritis and adult-onset still\u2019s disease: a multicenter Spanish study. Rheumatol Int. 2024;44:2911\u201320. https:\/\/doi.org\/10.1007\/s00296-024-05658-6.","journal-title":"Rheumatol Int"},{"key":"9723_CR82","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1136\/ard-2024-225853","volume":"83","author":"A De Matteis","year":"2024","unstructured":"De Matteis A, Bindoli S, De Benedetti F, Carmona L, Fautrel B, Mitrovic S. Systemic juvenile idiopathic arthritis and adult-onset still\u2019s disease are the same disease: evidence from systematic reviews and meta-analyses informing the 2023 EULAR\/PReS recommendations for the diagnosis and management of still\u2019s disease. Ann Rheum Dis. 2024;83:1748\u201361. https:\/\/doi.org\/10.1136\/ard-2024-225853.","journal-title":"Ann Rheum Dis"},{"key":"9723_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-023-03032-8","volume":"25","author":"N Inoue","year":"2023","unstructured":"Inoue N, Schulert GS. Mouse models of systemic juvenile idiopathic arthritis and macrophage activation syndrome. Arthritis Res Ther. 2023;25:48. https:\/\/doi.org\/10.1186\/s13075-023-03032-8.","journal-title":"Arthritis Res Ther"},{"key":"9723_CR84","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.tifs.2019.03.017","volume":"88","author":"S Fern\u00e1ndez-Tom\u00e9","year":"2019","unstructured":"Fern\u00e1ndez-Tom\u00e9 S, Hern\u00e1ndez-Ledesma B, Chaparro M, Indiano-Romacho P, Bernardo D, Gisbert JP. Role of food proteins and bioactive peptides in inflammatory bowel disease. Trends Food Sci Technol. 2019;88:194\u2013206. https:\/\/doi.org\/10.1016\/j.tifs.2019.03.017.","journal-title":"Trends Food Sci Technol"},{"key":"9723_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1155077","volume":"14","author":"K Wang","year":"2023","unstructured":"Wang K, Mao T, Lu X, Wang M, Yun Y, Jia Z, et al. A potential therapeutic approach for ulcerative colitis: targeted regulation of macrophage polarization through phytochemicals. Front Immunol. 2023;14:1155077. https:\/\/doi.org\/10.3389\/fimmu.2023.1155077.","journal-title":"Front Immunol"},{"key":"9723_CR86","doi-asserted-by":"publisher","DOI":"10.1007\/s00005-020-00576-4","volume":"68","author":"SS Seyedizade","year":"2020","unstructured":"Seyedizade SS, Afshari K, Bayat S, Rahmani F, Momtaz S, Rezaei N, et al. Current status of M1 and M2 macrophages pathway as drug targets for inflammatory bowel disease. Arch Immunol Ther Exp. 2020;68:10. https:\/\/doi.org\/10.1007\/s00005-020-00576-4.","journal-title":"Arch Immunol Ther Exp"},{"key":"9723_CR87","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.jconrel.2020.01.047","volume":"320","author":"J Zhang","year":"2020","unstructured":"Zhang J, Zhao Y, Hou T, Zeng H, Kalambhe D, Wang B, et al. Macrophage-based nanotherapeutic strategies in ulcerative colitis. J Control Release. 2020;320:363\u201380. https:\/\/doi.org\/10.1016\/j.jconrel.2020.01.047.","journal-title":"J Control Release"},{"key":"9723_CR88","doi-asserted-by":"publisher","first-page":"5703","DOI":"10.18632\/aging.205672","volume":"16","author":"R Du","year":"2024","unstructured":"Du R, Chen S, Han C, He Z, Pei H, Yang Y. M1 intestinal macrophages-derived exosomes promote colitis progression and mucosal barrier injury. Aging (Milano). 2024;16:5703\u201310. https:\/\/doi.org\/10.18632\/aging.205672.","journal-title":"Aging (Milano)"},{"key":"9723_CR89","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1111\/jcmm.16348","volume":"25","author":"J Lu","year":"2021","unstructured":"Lu J, Liu D, Tan Y, Deng F, Li R. M1 macrophage exosomes miR-21a\u20105p aggravates inflammatory bowel disease through decreasing E\u2010cadherin and subsequent ILC2 activation. J Cell Mol Med. 2021;25:3041\u201350. https:\/\/doi.org\/10.1111\/jcmm.16348.","journal-title":"J Cell Mol Med"},{"key":"9723_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110447","volume":"121","author":"X Chang","year":"2023","unstructured":"Chang X, Song Y-H, Xia T, He Z-X, Zhao S-B, Wang Z-J, et al. Macrophage-derived exosomes promote intestinal mucosal barrier dysfunction in inflammatory bowel disease by regulating TMIGD1 via mircroRNA-223. Int Immunopharmacol. 2023;121:110447. https:\/\/doi.org\/10.1016\/j.intimp.2023.110447.","journal-title":"Int Immunopharmacol"},{"key":"9723_CR91","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/ecco-jcc\/jjaa214","volume":"15","author":"F Deng","year":"2021","unstructured":"Deng F, Yan J, Lu J, Luo M, Xia P, Liu S, et al. M2 macrophage-derived exosomal miR-590-3p attenuates DSS-induced mucosal damage and promotes epithelial repair via the LATS1\/YAP\/ \u03b2-catenin signalling axis. J Crohns Colitis. 2021;15:665\u201377. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaa214.","journal-title":"J Crohns Colitis"},{"key":"9723_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117731","volume":"181","author":"M Biagioli","year":"2024","unstructured":"Biagioli M, Di Giorgio C, Massa C, Marchian\u00f2 S, Bellini R, Bordoni M, et al. Microbial-derived bile acid reverses inflammation in IBD via GPBAR1 agonism and ROR\u03b3t inverse agonism. Biomed Pharmacother. 2024;181:117731. https:\/\/doi.org\/10.1016\/j.biopha.2024.117731.","journal-title":"Biomed Pharmacother"},{"key":"9723_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156153","volume":"135","author":"Q Xiao","year":"2024","unstructured":"Xiao Q, Luo L, Zhu X, Yan Y, Li S, Chen L, et al. Formononetin alleviates ulcerative colitis via reshaping the balance of M1\/M2 macrophage polarization in a gut microbiota-dependent manner. Phytomedicine. 2024;135:156153. https:\/\/doi.org\/10.1016\/j.phymed.2024.156153.","journal-title":"Phytomedicine"},{"key":"9723_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113671","volume":"144","author":"Y Cai","year":"2025","unstructured":"Cai Y, Huang Y, Wang Y, Lin C, Qiu L, Wei H. Lactobacillus johnsonii GLJ001 prevents DSS-induced colitis in mice by inhibiting M1 macrophage polarization via gut microbiota-SCFAs axis. Int Immunopharmacol. 2025;144:113671. https:\/\/doi.org\/10.1016\/j.intimp.2024.113671.","journal-title":"Int Immunopharmacol"},{"key":"9723_CR95","doi-asserted-by":"publisher","first-page":"12722","DOI":"10.1080\/21655979.2021.2010368","volume":"12","author":"Y-X Wang","year":"2021","unstructured":"Wang Y-X, Lin C, Cui L-J, Deng T-Z, Li Q-M, Chen F-Y, et al. Mechanism of M2 macrophage-derived extracellular vesicles carrying LncRNA MEG3 in inflammatory responses in ulcerative colitis. Bioengineered. 2021;12:12722\u201339. https:\/\/doi.org\/10.1080\/21655979.2021.2010368.","journal-title":"Bioengineered"},{"key":"9723_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102558","volume":"58","author":"D Han","year":"2022","unstructured":"Han D, Lu D, Huang S, Pang J, Wu Y, Hu J, et al. Small extracellular vesicles from Ptpn1-deficient macrophages alleviate intestinal inflammation by reprogramming macrophage polarization via lactadherin enrichment. Redox Biol. 2022;58:102558. https:\/\/doi.org\/10.1016\/j.redox.2022.102558.","journal-title":"Redox Biol"},{"key":"9723_CR97","doi-asserted-by":"publisher","first-page":"138931","DOI":"10.1016\/j.ijbiomac.2024.138931","volume":"291","author":"C Ma","year":"2024","unstructured":"Ma C, Zheng X, Zhang Q, Renaud SJ, Yu H, Xu Y, et al. A postbiotic exopolysaccharide synergizes with Lactobacillus acidophilus to reduce intestinal inflammation in a mouse model of colitis. Int J Biol Macromol. 2024;291:138931. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.138931.","journal-title":"Int J Biol Macromol"},{"key":"9723_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252413629","volume":"25","author":"E Jim\u00e9nez","year":"2024","unstructured":"Jim\u00e9nez E, V\u00e1zquez A, Gonz\u00e1lez S, Saced\u00f3n R, Fern\u00e1ndez-Sevilla LM, Varas A, et al. Mucosal bacterial immunotherapy attenuates the development of experimental colitis by reducing inflammation through the regulation of myeloid cells. Int J Mol Sci. 2024;25:13629. https:\/\/doi.org\/10.3390\/ijms252413629.","journal-title":"Int J Mol Sci"},{"key":"9723_CR99","doi-asserted-by":"publisher","first-page":"109804","DOI":"10.1016\/j.jnutbio.2024.109804","volume":"136","author":"X Cao","year":"2025","unstructured":"Cao X, Li L, Hu J, Zhu S, Song S, Kong S, et al. Neohesperidin protects against colitis-associated colorectal cancer in mice via suppression of the NF-\u03baB\/p65 and MAPK pathways. J Nutr Biochem. 2025;136:109804. https:\/\/doi.org\/10.1016\/j.jnutbio.2024.109804.","journal-title":"J Nutr Biochem"},{"key":"9723_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118733","volume":"336","author":"Z Wei","year":"2025","unstructured":"Wei Z, Ni X, Cui H, Shu C, Peng Y, Liu J, et al. Engeletin attenuates the inflammatory response via inhibiting TLR4-NF\u03baB signaling pathway in crohn\u2019s disease-like colitis. J Ethnopharmacol. 2025;336:118733. https:\/\/doi.org\/10.1016\/j.jep.2024.118733.","journal-title":"J Ethnopharmacol"},{"key":"9723_CR101","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202207350","volume":"19","author":"Q Huang","year":"2023","unstructured":"Huang Q, Yang Y, Zhu Y, Chen Q, Zhao T, Xiao Z, et al. Oral metal-free melanin nanozymes for natural and durable targeted treatment of inflammatory bowel disease (IBD). Small. 2023;19:e2207350. https:\/\/doi.org\/10.1002\/smll.202207350.","journal-title":"Small"},{"key":"9723_CR102","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.actbio.2023.02.026","volume":"161","author":"M Bao","year":"2023","unstructured":"Bao M, Wang K, Li J, Li Y, Zhu H, Lu M, et al. ROS scavenging and inflammation-directed polydopamine nanoparticles regulate gut immunity and flora therapy in inflammatory bowel disease. Acta Biomater. 2023;161:250\u201364. https:\/\/doi.org\/10.1016\/j.actbio.2023.02.026.","journal-title":"Acta Biomater"},{"key":"9723_CR103","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202304002","volume":"10","author":"J Cheng","year":"2023","unstructured":"Cheng J, Zhang Y, Ma L, Du W, Zhang Q, Gao R, et al. Macrophage-derived extracellular vesicles-coated palladium nanoformulations modulate inflammatory and immune homeostasis for targeting therapy of ulcerative colitis. Adv Sci. 2023;10:e2304002. https:\/\/doi.org\/10.1002\/advs.202304002.","journal-title":"Adv Sci"},{"key":"9723_CR104","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21207477","volume":"21","author":"K Nijakowski","year":"2020","unstructured":"Nijakowski K, Surdacka A. Salivary biomarkers for diagnosis of inflammatory bowel diseases: a systematic review. Int J Mol Sci. 2020;21:7477. https:\/\/doi.org\/10.3390\/ijms21207477.","journal-title":"Int J Mol Sci"},{"key":"9723_CR105","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-021-00280-x","volume":"26","author":"J Shao","year":"2021","unstructured":"Shao J, Jin Y, Shao C, Fan H, Wang X, Yang G. Serum exosomal pregnancy zone protein as a promising biomarker in inflammatory bowel disease. Cell Mol Biol Lett. 2021;26:36. https:\/\/doi.org\/10.1186\/s11658-021-00280-x.","journal-title":"Cell Mol Biol Lett"},{"key":"9723_CR106","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41423-021-00768-8","volume":"19","author":"B Terziroli Beretta-Piccoli","year":"2022","unstructured":"Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D. Autoimmmune hepatitis. Cell Mol Immunol. 2022;19:158\u201376. https:\/\/doi.org\/10.1038\/s41423-021-00768-8.","journal-title":"Cell Mol Immunol"},{"key":"9723_CR107","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1177\/2050640619872408","volume":"7","author":"S Pape","year":"2019","unstructured":"Pape S, Schramm C, Gevers TJ. Clinical management of autoimmune hepatitis. United Eur Gastroenterol J. 2019;7:1156\u201363. https:\/\/doi.org\/10.1177\/2050640619872408.","journal-title":"United Eur Gastroenterol J"},{"key":"9723_CR108","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3350\/cmh.2020.0189","volume":"27","author":"A Komori","year":"2021","unstructured":"Komori A. Recent updates on the management of autoimmune hepatitis. Clin Mol Hepatol. 2021;27:58\u201369. https:\/\/doi.org\/10.3350\/cmh.2020.0189.","journal-title":"Clin Mol Hepatol"},{"key":"9723_CR109","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.303","volume":"4","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Hong L, Li X, Li Y, Zhang X, Jiang J, et al. M1 macrophage-derived exosomes promote autoimmune liver injury by transferring long noncoding RNA H19 to hepatocytes. MedComm. 2023;4:e303. https:\/\/doi.org\/10.1002\/mco2.303.","journal-title":"MedComm"},{"key":"9723_CR110","doi-asserted-by":"publisher","first-page":"5536","DOI":"10.1021\/acsami.3c16168","volume":"16","author":"C Fei","year":"2024","unstructured":"Fei C, Liu L, Qi H, Peng Y, Han J, Wang C, et al. Curdlan-decorated fullerenes mitigate immune-mediated hepatic injury for autoimmune hepatitis therapeutics via reducing macrophage infiltration. ACS Appl Mater Interfaces. 2024;16:5536\u201347. https:\/\/doi.org\/10.1021\/acsami.3c16168.","journal-title":"ACS Appl Mater Interfaces"},{"key":"9723_CR111","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1136\/gutjnl-2020-322362","volume":"70","author":"PJ Trivedi","year":"2021","unstructured":"Trivedi PJ, Hirschfield GM. Recent advances in clinical practice: epidemiology of autoimmune liver diseases. Gut. 2021;70:1989\u20132003. https:\/\/doi.org\/10.1136\/gutjnl-2020-322362.","journal-title":"Gut"},{"key":"9723_CR112","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.jhep.2021.12.041","volume":"76","author":"S Pape","year":"2022","unstructured":"Pape S, Snijders RJALM, Gevers TJG, Chazouilleres O, Dalekos GN, Hirschfield GM, et al. Systematic review of response criteria and endpoints in autoimmune hepatitis by the international autoimmune hepatitis group. J Hepatol. 2022;76:841\u20139. https:\/\/doi.org\/10.1016\/j.jhep.2021.12.041.","journal-title":"J Hepatol"},{"key":"9723_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155586","volume":"133","author":"J Lu","year":"2024","unstructured":"Lu J, Gu X, Xue C, Shi Q, Jia J, Cheng J, et al. Glycyrrhizic acid alleviates concanavalin a-induced acute liver injury by regulating monocyte-derived macrophages. Phytomedicine. 2024;133:155586. https:\/\/doi.org\/10.1016\/j.phymed.2024.155586.","journal-title":"Phytomedicine"},{"key":"9723_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116161","volume":"171","author":"L Zhang","year":"2024","unstructured":"Zhang L, Liu M, Sun Q, Cheng S, Chi Y, Zhang J, et al. Engineering M2 type macrophage-derived exosomes for autoimmune hepatitis immunotherapy via loading siRIPK3. Biomed Pharmacother. 2024;171:116161. https:\/\/doi.org\/10.1016\/j.biopha.2024.116161.","journal-title":"Biomed Pharmacother"},{"key":"9723_CR115","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1016\/S0140-6736(18)31320-5","volume":"391","author":"LA DiMeglio","year":"2018","unstructured":"DiMeglio LA, Evans-Molina C, Oram RA. Type 1 diabetes. Lancet. 2018;391:2449\u201362. https:\/\/doi.org\/10.1016\/S0140-6736(18)31320-5.","journal-title":"Lancet"},{"key":"9723_CR116","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.16","volume":"3","author":"A Katsarou","year":"2017","unstructured":"Katsarou A, Gudbj\u00f6rnsdottir S, Rawshani A, Dabelea D, Bonifacio E, Anderson BJ, et al. Type 1 diabetes mellitus. Nat Rev Dis Primers. 2017;3:17016. https:\/\/doi.org\/10.1038\/nrdp.2017.16.","journal-title":"Nat Rev Dis Primers"},{"key":"9723_CR117","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrendo.2009.21","volume":"5","author":"DL Eizirik","year":"2009","unstructured":"Eizirik DL, Colli ML, Ortis F. The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol. 2009;5:219\u201326. https:\/\/doi.org\/10.1038\/nrendo.2009.21.","journal-title":"Nat Rev Endocrinol"},{"issue":"11","key":"9723_CR118","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41574-020-00409-6","volume":"16","author":"DL Eizirik","year":"2020","unstructured":"Eizirik DL, Colli ML. Revisiting the role of inflammation in the loss of pancreatic \u03b2-cells in T1DM. Nat Rev Endocrinol. 2020;16(11):611\u20132. https:\/\/doi.org\/10.1038\/s41574-020-00409-6.","journal-title":"Nat Rev Endocrinol"},{"key":"9723_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e11995","volume":"8","author":"Y Yu","year":"2022","unstructured":"Yu Y, Li M, Zhao Y, Fan F, Wu W, Gao Y, et al. Immune cell-derived extracellular vesicular microRNAs induce pancreatic beta cell apoptosis. Heliyon. 2022;8:e11995. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e11995.","journal-title":"Heliyon"},{"key":"9723_CR120","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.865782","volume":"13","author":"S Soltani","year":"2022","unstructured":"Soltani S, Mansouri K, Emami Aleagha MS, Moasefi N, Yavari N, Shakouri SK, et al. Extracellular vesicle therapy for type 1 diabetes. Front Immunol. 2022;13:865782. https:\/\/doi.org\/10.3389\/fimmu.2022.865782.","journal-title":"Front Immunol"},{"key":"9723_CR121","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cmet.2019.11.017","volume":"31","author":"JT Warshauer","year":"2020","unstructured":"Warshauer JT, Bluestone JA, Anderson MS. New frontiers in the treatment of type 1 diabetes. Cell Metab. 2020;31:46\u201361. https:\/\/doi.org\/10.1016\/j.cmet.2019.11.017.","journal-title":"Cell Metab"},{"key":"9723_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2021.101063","volume":"83","author":"E Zeynaloo","year":"2022","unstructured":"Zeynaloo E, Stone LD, Dikici E, Ricordi C, Deo SK, Bachas LG, et al. Delivery of therapeutic agents and cells to pancreatic islets: towards a new era in the treatment of diabetes. Mol Aspects Med. 2022;83:101063. https:\/\/doi.org\/10.1016\/j.mam.2021.101063.","journal-title":"Mol Aspects Med"},{"key":"9723_CR123","doi-asserted-by":"publisher","first-page":"e2401423","DOI":"10.1002\/advs.202401423","volume":"11","author":"Z Zhou","year":"2024","unstructured":"Zhou Z, Mukundan N, Zhang JA, Wu Y-T, Zhang Q, Wang D, et al. Macrophage-mimicking cellular nanoparticles scavenge proinflammatory cytokines in specimens of patients with inflammatory disorders. Adv Sci (Weinh Baden-Wurtt Ger). 2024;11:e2401423. https:\/\/doi.org\/10.1002\/advs.202401423.","journal-title":"Adv Sci (Weinh Baden-Wurtt Ger)"},{"key":"9723_CR124","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.2337\/db23-0987","volume":"73","author":"Z Yang","year":"2024","unstructured":"Yang Z, Zhang Z, Li L, Jing Z, Ma Y, Lan T, et al. Bioengineered artificial extracellular vesicles presenting PD-L1 and gal-9 ameliorate new-onset type 1 diabetes. Diabetes. 2024;73:1325\u201335. https:\/\/doi.org\/10.2337\/db23-0987.","journal-title":"Diabetes"},{"key":"9723_CR125","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1080\/21691401.2019.1669617","volume":"47","author":"M Li","year":"2019","unstructured":"Li M, Wang T, Tian H, Wei G, Zhao L, Shi Y. Macrophage-derived exosomes accelerate wound healing through their anti-inflammation effects in a diabetic rat model. Artif Cells Nanomed Biotechnol. 2019;47:3793\u2013803. https:\/\/doi.org\/10.1080\/21691401.2019.1669617.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"9723_CR126","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.13819","volume":"26","author":"R Dobson","year":"2019","unstructured":"Dobson R, Giovannoni G. Multiple sclerosis - a review. Eur J Neurol. 2019;26:27\u201340. https:\/\/doi.org\/10.1111\/ene.13819.","journal-title":"Eur J Neurol"},{"key":"9723_CR127","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1097\/WCO.0000000000000622","volume":"31","author":"J Oh","year":"2018","unstructured":"Oh J, Vidal-Jordana A, Montalban X. Multiple sclerosis: clinical aspects. Curr Opin Neurol. 2018;31:752\u20139. https:\/\/doi.org\/10.1097\/WCO.0000000000000622.","journal-title":"Curr Opin Neurol"},{"key":"9723_CR128","doi-asserted-by":"publisher","DOI":"10.1126\/science.aav7188","volume":"365","author":"International Multiple Sclerosis Genetics Consortium","year":"2019","unstructured":"International Multiple Sclerosis Genetics Consortium. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science. 2019;365:eaav7188. https:\/\/doi.org\/10.1126\/science.aav7188.","journal-title":"Science"},{"key":"9723_CR129","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41577-023-00907-4","volume":"24","author":"SA Kent","year":"2024","unstructured":"Kent SA, Miron VE. Microglia regulation of central nervous system myelin health and regeneration. Nat Rev Immunol. 2024;24:49\u201363. https:\/\/doi.org\/10.1038\/s41577-023-00907-4.","journal-title":"Nat Rev Immunol"},{"key":"9723_CR130","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-024-03019-5","volume":"21","author":"X-Y Ji","year":"2024","unstructured":"Ji X-Y, Guo Y-X, Wang L-B, Wu W-C, Wang J-Q, He J, et al. Microglia-derived exosomes modulate myelin regeneration via miR-615-5p\/MYRF axis. J Neuroinflammation. 2024;21:29. https:\/\/doi.org\/10.1186\/s12974-024-03019-5.","journal-title":"J Neuroinflammation"},{"key":"9723_CR131","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-024-03243-z","volume":"21","author":"J Duan","year":"2024","unstructured":"Duan J, Lv A, Guo Z, Liu Q, Tian C, Yang Y, et al. CX3CR1+\/UCHL1\u2009+\u2009microglial extracellular vesicles in blood: a potential biomarker for multiple sclerosis. J Neuroinflammation. 2024;21:254. https:\/\/doi.org\/10.1186\/s12974-024-03243-z.","journal-title":"J Neuroinflammation"},{"key":"9723_CR132","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.jconrel.2022.12.026","volume":"353","author":"X Zheng","year":"2023","unstructured":"Zheng X, Sun K, Liu Y, Yin X, Zhu H, Yu F, et al. Resveratrol-loaded macrophage exosomes alleviate multiple sclerosis through targeting microglia. J Control Release. 2023;353:675\u201384. https:\/\/doi.org\/10.1016\/j.jconrel.2022.12.026.","journal-title":"J Control Release"},{"key":"9723_CR133","doi-asserted-by":"publisher","first-page":"779","DOI":"10.4103\/NRR.NRR-D-23-01508","volume":"20","author":"G Zhang","year":"2025","unstructured":"Zhang G, Yao Q, Long C, Yi P, Song J, Wu L, et al. Infiltration by monocytes of the central nervous system and its role in multiple sclerosis: reflections on therapeutic strategies. Neural Regen Res. 2025;20:779\u201393. https:\/\/doi.org\/10.4103\/NRR.NRR-D-23-01508.","journal-title":"Neural Regen Res"},{"key":"9723_CR134","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/S0140-6736(21)00517-1","volume":"397","author":"N Shahrizaila","year":"2021","unstructured":"Shahrizaila N, Lehmann HC, Kuwabara S. Guillain-barr\u00e9 syndrome. Lancet. 2021;397:1214\u201328. https:\/\/doi.org\/10.1016\/S0140-6736(21)00517-1.","journal-title":"Lancet"},{"key":"9723_CR135","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13184","volume":"34","author":"J-M Vallat","year":"2024","unstructured":"Vallat J-M, Mathis S. Pathology explains various mechanisms of auto-immune inflammatory peripheral neuropathies. Brain Pathol. 2024;34:e13184. https:\/\/doi.org\/10.1111\/bpa.13184.","journal-title":"Brain Pathol"},{"key":"9723_CR136","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/s0165-5728(97)00238-5","volume":"84","author":"J Zhu","year":"1998","unstructured":"Zhu J, Mix E, Link H. Cytokine production and the pathogenesis of experimental autoimmune neuritis and Guillain-Barr\u00e9 syndrome. J Neuroimmunol. 1998;84:40\u201352. https:\/\/doi.org\/10.1016\/s0165-5728(97)00238-5.","journal-title":"J Neuroimmunol"},{"key":"9723_CR137","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1056\/NEJMra1114525","volume":"366","author":"N Yuki","year":"2012","unstructured":"Yuki N, Hartung H-P. Guillain-Barr\u00e9 syndrome. N Engl J Med. 2012;366:2294\u2013304. https:\/\/doi.org\/10.1056\/NEJMra1114525.","journal-title":"N Engl J Med"},{"key":"9723_CR138","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.cytogfr.2013.05.005","volume":"24","author":"H-L Zhang","year":"2013","unstructured":"Zhang H-L, Zheng X-Y, Zhu J. Th1\/Th2\/Th17\/Treg cytokines in Guillain-Barr\u00e9 syndrome and experimental autoimmune neuritis. Cytokine Growth Factor Rev. 2013;24:443\u201353. https:\/\/doi.org\/10.1016\/j.cytogfr.2013.05.005.","journal-title":"Cytokine Growth Factor Rev"},{"key":"9723_CR139","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01603","volume":"11","author":"T Du","year":"2020","unstructured":"Du T, Yang C-L, Ge M-R, Liu Y, Zhang P, Li H, et al. M1 macrophage derived exosomes aggravate experimental autoimmune neuritis via modulating Th1 response. Front Immunol. 2020;11:1603. https:\/\/doi.org\/10.3389\/fimmu.2020.01603.","journal-title":"Front Immunol"},{"key":"9723_CR140","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1159\/000494793","volume":"50","author":"L Wang","year":"2018","unstructured":"Wang L, Wang C, Jia X, Yu J. Circulating exosomal miR-17 inhibits the induction of regulatory T cells via suppressing TGFBR II expression in rheumatoid arthritis. Cell Physiol Biochem. 2018;50:1754\u201363. https:\/\/doi.org\/10.1159\/000494793.","journal-title":"Cell Physiol Biochem"},{"key":"9723_CR141","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1326836","volume":"14","author":"F Chen","year":"2023","unstructured":"Chen F, Shi B, Liu W, Gong J, Gao J, Sun Y, et al. Circulating exosomal microRNAs as biomarkers of lupus nephritis. Front Immunol. 2023;14:1326836. https:\/\/doi.org\/10.3389\/fimmu.2023.1326836.","journal-title":"Front Immunol"},{"key":"9723_CR142","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2023-001078","volume":"11","author":"P Somparn","year":"2024","unstructured":"Somparn P, Srichaimongkol A, Jungjing S, Wanthong B, Nanthawong S, Asada L, et al. Potential involvement of circulating exosomal miRNA-146a in disease activity and TRAF6 gene expression in juvenile proliferative lupus nephritis. Lupus Sci Med. 2024;11:e001078. https:\/\/doi.org\/10.1136\/lupus-2023-001078.","journal-title":"Lupus Sci Med"},{"key":"9723_CR143","doi-asserted-by":"publisher","DOI":"10.1177\/2040622321991705","volume":"12","author":"R Liu","year":"2021","unstructured":"Liu R, Jiang C, Li J, Li X, Zhao L, Yun H, et al. Serum-derived exosomes containing NEAT1 promote the occurrence of rheumatoid arthritis through regulation of miR-144-3p\/ROCK2 axis. Ther Adv Chronic Dis. 2021;12:2040622321991705. https:\/\/doi.org\/10.1177\/2040622321991705.","journal-title":"Ther Adv Chronic Dis"},{"key":"9723_CR144","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinsp.2024.100441","volume":"79","author":"J Lu","year":"2024","unstructured":"Lu J, Wu J, Zhang X, Zhong R, Wang B, Yang H, et al. Characterization of the microRNA profile in rheumatoid arthritis plasma exosomes and their roles in B-cell responses. Clinics (Sao Paulo). 2024;79:100441. https:\/\/doi.org\/10.1016\/j.clinsp.2024.100441.","journal-title":"Clinics (Sao Paulo)"},{"key":"9723_CR145","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1077645","volume":"14","author":"S Chen","year":"2023","unstructured":"Chen S, Zhang X, Meng K, Sun Y, Shu R, Han Y, et al. Urinary exosome TsRNAs as novel markers for diagnosis and prediction of lupus nephritis. Front Immunol. 2023;14:1077645. https:\/\/doi.org\/10.3389\/fimmu.2023.1077645.","journal-title":"Front Immunol"},{"key":"9723_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111735","volume":"130","author":"S Sun","year":"2024","unstructured":"Sun S, Liang L, Tian R, Huang Q, Ji Z, Li X, et al. LncRNA expression profiling in exosomes derived from synovial fluid of patients with rheumatoid arthritis. Int Immunopharmacol. 2024;130:111735. https:\/\/doi.org\/10.1016\/j.intimp.2024.111735.","journal-title":"Int Immunopharmacol"},{"key":"9723_CR147","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/ecco-jcc\/jjz184","volume":"14","author":"C Yang","year":"2020","unstructured":"Yang C, Zhang M, Sung J, Wang L, Jung Y, Merlin D. Autologous exosome transfer: a new personalised treatment concept to prevent colitis in a murine model. J Crohns Colitis. 2020;14:841\u201355. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjz184.","journal-title":"J Crohns Colitis"},{"key":"9723_CR148","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/emmm.201201846","volume":"5","author":"N Cloutier","year":"2013","unstructured":"Cloutier N, Tan S, Boudreau LH, Cramb C, Subbaiah R, Lahey L, et al. The exposure of autoantigens by microparticles underlies the formation of potent inflammatory components: the microparticle-associated immune complexes. EMBO Mol Med. 2013;5:235\u201349. https:\/\/doi.org\/10.1002\/emmm.201201846.","journal-title":"EMBO Mol Med"},{"key":"9723_CR149","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1419683","volume":"15","author":"H Wu","year":"2024","unstructured":"Wu H, Chen Q, Wang S, Yang C, Xu L, Xiao H, et al. Serum exosomes lncrnas: TCONS_I2_00013502 and ENST00000363624 are new diagnostic markers for rheumatoid arthritis. Front Immunol. 2024;15:1419683. https:\/\/doi.org\/10.3389\/fimmu.2024.1419683.","journal-title":"Front Immunol"},{"key":"9723_CR150","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.actbio.2024.01.043","volume":"177","author":"S Jin","year":"2024","unstructured":"Jin S, Wen J, Zhang Y, Mou P, Luo Z, Cai Y, et al. M2 macrophage-derived exosome-functionalized topological scaffolds regulate the foreign body response and the coupling of angio\/osteoclasto\/osteogenesis. Acta Biomater. 2024;177:91\u2013106. https:\/\/doi.org\/10.1016\/j.actbio.2024.01.043.","journal-title":"Acta Biomater"},{"key":"9723_CR151","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-025-04078-9","volume":"25","author":"A Habibi","year":"2025","unstructured":"Habibi A, Khosravi A, Soleimani M, Nejabat M, Dara M, Azarpira N. Efficacy of topical mesenchymal stem cell exosome in Sj\u00f6gren\u2019s syndrome-related dry eye: a randomized clinical trial. BMC Ophthalmol. 2025;25:299. https:\/\/doi.org\/10.1186\/s12886-025-04078-9.","journal-title":"BMC Ophthalmol"},{"key":"9723_CR152","unstructured":"Guangdong ProCapZoom Biosciences Co., Ltd. Exploratory clinical trial of exosomes in patients with ocular involvement of sj\u00f6gren\u2019s syndrome [Internet]. clinicaltrials.gov;2025 Sept. Report No.: NCT07192666. https:\/\/clinicaltrials.gov\/study\/NCT07192666. Accessed 6 Oct 2025."},{"key":"9723_CR153","unstructured":"Hassani AS. A clinical study for safety and efficacy evaluation of limbal stem cell derived exosome (LSC-exo) eye drop for treatment of dry eye syndrome [Internet]. clinicaltrials.gov; 2025 Apr. Report No.: NCT06543667. https:\/\/clinicaltrials.gov\/study\/NCT06543667. Accessed 6 Oct 2025."},{"key":"9723_CR154","unstructured":"Peskau A. Allogeneic mesenchymal stem cell-derived exosome therapy for progressive multiple sclerosis [Internet]. clinicaltrials.gov; 2025 Aug. Report No.: NCT07146087. https:\/\/clinicaltrials.gov\/study\/NCT07146087. Accessed 6 Oct 2025."},{"key":"9723_CR155","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.semcancer.2023.02.002","volume":"90","author":"DW Greening","year":"2023","unstructured":"Greening DW, Xu R, Ale A, Hagemeyer CE, Chen W. Extracellular vesicles as next generation immunotherapeutics. Semin Cancer Biol. 2023;90:73\u2013100. https:\/\/doi.org\/10.1016\/j.semcancer.2023.02.002.","journal-title":"Semin Cancer Biol"},{"key":"9723_CR156","doi-asserted-by":"publisher","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Th\u00e9ry","year":"2018","unstructured":"Th\u00e9ry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the international society for extracellular vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7:1535750. https:\/\/doi.org\/10.1080\/20013078.2018.1535750.","journal-title":"J Extracell Vesicles"},{"key":"9723_CR157","doi-asserted-by":"publisher","first-page":"1518008","DOI":"10.3389\/fimmu.2024.1518008","volume":"15","author":"K Lv","year":"2024","unstructured":"Lv K, Liang Q. Macrophages in sepsis-induced acute lung injury: exosomal modulation and therapeutic potential. Front Immunol. 2024;15:1518008. https:\/\/doi.org\/10.3389\/fimmu.2024.1518008.","journal-title":"Front Immunol"},{"key":"9723_CR158","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.cmet.2022.05.008","volume":"34","author":"H Gao","year":"2022","unstructured":"Gao H, Jin Z, Bandyopadhyay G, e Rocha KC, Liu X, Zhao H, et al. MiR-690 treatment causes decreased fibrosis, steatosis and restores specific Kupffer cell functions in NASH. Cell Metab. 2022;34:978\u2013e9904. https:\/\/doi.org\/10.1016\/j.cmet.2022.05.008.","journal-title":"Cell Metab"},{"key":"9723_CR159","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00032.2024","author":"K-S Park","year":"2025","unstructured":"Park K-S, L\u00e4sser C, L\u00f6tvall J. Extracellular vesicles and the lung: from disease pathogenesis to biomarkers and treatments. Physiol Rev. 2025. https:\/\/doi.org\/10.1152\/physrev.00032.2024.","journal-title":"Physiol Rev"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-025-09723-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-025-09723-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-025-09723-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T07:29:24Z","timestamp":1770190164000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-025-09723-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":159,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["9723"],"URL":"https:\/\/doi.org\/10.1007\/s12026-025-09723-5","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"29 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"171"}}